Login / Signup

Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent.

Dongsheng LiuAamir SaeedSidra MajazBashrat AhmadAshfaq AhmadYingqiu Xie
Published in: Journal of translational medicine (2023)
Keyphrases
  • coronavirus disease
  • sars cov
  • low dose
  • high dose
  • drug induced
  • cancer therapy
  • early onset
  • human health
  • sleep quality
  • respiratory syndrome coronavirus
  • emergency department
  • depressive symptoms
  • drug delivery